You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 22, December 8, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Breast Cancer
 •Radiologic Imaging
 •Women's Health
 •Women's Health, Other
 •Magnetic Resonance Imaging
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Magnetic Resonance Imaging in Breast Cancer

One Step Forward, Two Steps Back?

Monica Morrow, MD

JAMA. 2004;292:2779-2780.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The use of magnetic resonance imaging (MRI) of the breast is being examined in 2 distinct settings: as a screening test in women at high risk for breast cancer development such as those with mutations of the BRCA1 and BRCA2 genes; and as an adjunct to mammography for the selection of local therapy in women with known or suspected breast cancer. The rationale for these 2 approaches is quite different. In women with predisposition mutations, breast cancer often occurs at an early age when dense breast tissue decreases the sensitivity of mammographic screening1-2 and interval cancers are common2 due to the histological features and rapid growth rates of cancerous tumors occurring in mutation carriers.3-5 These observations provide a strong biological rationale for examining alternative screening methods, particularly those not influenced by breast density. Two recent prospective trials6-7 suggest that MRI screening in this high-risk population is a . . . [Full Text of this Article]

Author Affiliation: Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pa.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Magnetic Resonance Imaging of the Breast Prior to Biopsy
David A. Bluemke, Constantine A. Gatsonis, Mei Hsiu Chen, Gia A. DeAngelis, Nanette DeBruhl, Steven Harms, Sylvia H. Heywang-Köbrunner, Nola Hylton, Christiane K. Kuhl, Constance Lehman, Etta D. Pisano, Petrina Causer, Stuart J. Schnitt, Stanley F. Smazal, Carol B. Stelling, Paul T. Weatherall, and Mitchell D. Schnall
JAMA. 2004;292(22):2735-2742.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relationship of Breast Magnetic Resonance Imaging to Outcome After Breast-Conservation Treatment With Radiation for Women With Early-Stage Invasive Breast Carcinoma or Ductal Carcinoma in Situ
Solin et al.
JCO 2008;26:386-391.
ABSTRACT | FULL TEXT  

Current Status of Breast MR Imaging * Part 2. Clinical Applications
Kuhl
Radiology 2007;244:672-691.
ABSTRACT | FULL TEXT  

Evaluating the Impact of Preoperative Breast Magnetic Resonance Imaging on the Surgical Management of Newly Diagnosed Breast Cancers
Bilimoria et al.
Arch Surg 2007;142:441-447.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.